Retro Biosciences

Retro is developing therapies intended to improve cellular maintenance and reverse aspects of biological aging.

Targeting shared mechanisms of aging could address several age-related diseases at once.

• ?Longevity biology remains uncertain.
• ?Early cellular results may not translate into durable patient outcomes.
• ?Clinical development will require substantial capital and time.

This catalog began with Core Memory coverage. The reporting is context, not an endorsement or investment recommendation.

Facts checked 2026-08-13. Company information comes from the public sources below. The company has not reviewed or endorsed it.